Clinical benefits of PD-1 inhibitors in specific subgroups of patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of phase 3 randomized clinical trials
Yao Lu(Johns Hopkins University), Feng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenkang Wang(ZheJiang Institute For Food and Drug Control)
Cited by 19
Related Papers
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
|Cell Death Discovery|2024|145
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity
|Cell Death and Disease|2023|130
Intensive Care Unit-Acquired Weakness: A Review of Recent Progress With a Look Toward the Future
|Frontiers in Medicine|2020|117
Extracellular vesicles remodel tumor environment for cancer immunotherapy
|Molecular Cancer|2023|105
Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson’s Disease Mice, Possibly via Impaired Glymphatic Clearance
|Journal of Molecular Neuroscience|2021|104